Delivery Order SPE2DB20D3103-SPE2DB25FM3H8

Award Date 1/15/25
Potential Completion Date 2/6/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,037.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA) in 0.25 mL doses. The contract is not designated as a set-aside and represents a single delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of 0.25 mL doses of the Moderna COVID-19 vaccine for the 6 month to 11 year old age group under the Emergency Use Authorization (EUA). The award, valued at $6,361.10, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 1, 2024. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. This appears to be a delivery order, likely part of a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $3,692.20 firm fixed-price contract is for the supply of Moderna COVID-19 vaccine doses for children aged 6 months to 11 years under the Emergency Use Authorization (EUA). This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 2025, which...
The U.S. Defense Logistics Agency (DLA) awarded a $2,215.32 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). This contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The award is for the supply of Moderna COVID-19 vaccines (0.25mL dosage) for the 6-month to 11-year old age group under an Emergency Use Authorization. The award has a ceiling value of $2,278.38 and an ultimate completion date of May 2, 2024. This delivery order is part of...
This federal contract award, valued at $1,908.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA), with an ultimate completion date of November 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of 0.25 mL doses of the Moderna COVID-19 vaccine for the 6-month to 11-year age group under the Emergency Use Authorization (EUA). The $1,290.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 30, 2024 and does not have a set-aside designation, indicating...
This federal contract award is for the delivery of 0.25 ML doses of the Moderna COVID-19 vaccine for individuals aged 6 months to 11 years, under the Emergency Use Authorization (EUA). The contract, valued at $7,384.40, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division on June 3, 2024, with a completion date of June 25, 2024. The contract is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency, on a Firm Fixed Price basis. It is not designated...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,605.08 firm fixed-price delivery order is for the supply of Moderna COVID-19 vaccines for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The award has an ultimate completion date of December 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with...
This is a $1,290 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of January 27, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM3H8
    Delivery Order

This is a $2,580.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. for the provision of 0.25mL doses of the Moderna COVID-19 vaccine for children aged 6 months to 11 years, under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of February 6, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 4/17/25, 8:41 AM